Fibroblast growth factor (FGF) 23 and FGF receptor 4 induced cardiac mitochondrial dysfunction as a new target in CKD?
Kidney International · 2025
DOI: 10.1016/j.kint.2025.02.017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney International, 2025. Verfasst von Dieter Haffner und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Kidney, Liver, Metabolic and Neurological Diseases, Hannover Medical School, Hannover, Germany. Electronic address: haffner.d…. Hauptthemen laut MEDLINE: Fibroblast Growth Factors, Renal Insufficiency, Chronic, Mitochondria, Heart, Receptor, Fibroblast Growth Factor, Type 4. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 8 Literaturangaben. Gefördert von: Chiesi Farmaceutici, Kyowa Kirin.
Abstract (Originalsprache)
Chronic kidney disease is associated with excessive cardiovascular mortality, which is promoted by the phosphaturic hormone fibroblast growth factor 23 (FGF23). Increased FGF23 levels result in left ventricular hypertrophy via activation of the FGF receptor 4 activation. Fuchs et al. now demonstrate, using bioengineered cardiobundles, neonatal rat ventricular myocytes, and mice with chronic kidney disease, that FGF23-FGF receptor 4 activation is a potential mechanism of cardiac mitochondrial dysfunction and metabolic remodeling as early complications of chronic kidney disease, preceding structural cardiac changes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Kidney, Liver, Metabolic and Neurological Diseases, Hannover Medical School, Hannover, Germany. Electronic address: haffner.dieter@mh-hannover.de.
- Department of Pediatric Kidney, Liver, Metabolic and Neurological Diseases, Hannover Medical School, Hannover, Germany.
Förderung
- Chiesi Farmaceutici
- Kyowa Kirin
Zitieren
APA
Haffner, D., & Leifheit-Nestler, M. (2025). Fibroblast growth factor (FGF) 23 and FGF receptor 4 induced cardiac mitochondrial dysfunction as a new target in CKD?. Kidney International. https://doi.org/10.1016/j.kint.2025.02.017
Vancouver
Haffner D, Leifheit-Nestler M. Fibroblast growth factor (FGF) 23 and FGF receptor 4 induced cardiac mitochondrial dysfunction as a new target in CKD?. Kidney International. 2025. doi:10.1016/j.kint.2025.02.017
BibTeX
@article{Haffner2025,
author = {Haffner, Dieter and Leifheit-Nestler, Maren},
title = {Fibroblast growth factor (FGF) 23 and FGF receptor 4 induced cardiac mitochondrial dysfunction as a new target in CKD?},
journal = {Kidney International},
year = {2025},
doi = {10.1016/j.kint.2025.02.017}
}
EUVIMED